Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

"M3-M6" Molecular Response Evolution As Early Predictor of Outcome Considering Generic Vs Branded TKIs for Chronic Myeloid Leukemia (CML): An Argentine Multicentric Study

Isabel Amanda Giere, PhD M.Sc, María Jose Mela Osorio, MD, Federico Andrés Klosowski, Mariana Debus, Federico Sackmann, MD, Miguel A Pavlovsky, MD, Isolda Fernandez, MD, Elena Beatriz Moiraghi, MD, Ana Inés Varela, MD, Mariel Ana Perez, MD, Julio M. Pose Cabarcos, MD, Georgina Bendek, MD, Romina Mariano, MD, Silvina Palmer, MD, Alicia Enrico, MD, Isabel Cristina Annetta, MD, Andres L. Brodsky, MD PhD, Dante Intile, Statistic MD, Carolina Pavlovsky, MD

Blood (2016) 128 (22): 5445.

https://doi.org/10.1182/blood.V128.22.5445.5445

Published: 2016

Journal Articles

Real-World Data from Long Term Follow-up in Chronic Myeloid Leukemia (CML) Patients (PTS) Treated with Imatinib. Predictive Factors for Achievement of Deep Molecular Responses and for Failure

María Jose Mela Osorio, MD, Isabel Amanda Giere, PhD M.Sc, Isolda Fernandez, MD, Miguel A Pavlovsky, MD, Guillermina Remaggi, MD, Federico Sackmann, Dante Intile, Statistic, Carolina Pavlovsky, MD

Blood (2015) 126 (23): 5169.

https://doi.org/10.1182/blood.V126.23.5169.5169

Published: 2015

Journal Articles

Abbreviated Regimen with 4 Cycles of Fludarabine, Cyclophosphamide and Rituximab (FCR) in Physically Fit Patients with Chronic Lymphocytic Leukemia Who Achieve Early Complete Remission with Undetectable Minimal Residual Disease: Safety and Efficacy Follow-up Results of a Single Center Experience

Carolina Pavlovsky, MD, Isolda Fernandez, MD, Miguel A Pavlovsky, MD, Adriana Galeano, Federico Sackmann, Dante Intile, Statistic, Astrid Pavlovsky, MD

Blood (2015) 126 (23): 1739.

https://doi.org/10.1182/blood.V126.23.1739.1739

Published: 2015

Journal Articles

Chronic Myeloid Leukemia (CML): BCR-ABL Transcript Levels Halving Time and Relative Reduction Ratio at Months 3 As New Predictors of Outcome. an Argentine Pilot Study

Isabel Amanda Giere, PhD M.Sc, María Jose Mela Osorio, MD, Federico Andrés Klosowski, Mariana Debus, Ana Inés Varela, MD, Elena Beatriz Moiraghi, MD, Miguel A Pavlovsky, MD, Isolda Fernandez, MD, Dante Intile, Statistic, Carolina Pavlovsky, MD

Blood (2015) 126 (23): 1590.

https://doi.org/10.1182/blood.V126.23.1590.1590

Published: 2015

Journal Articles

Safety and Efficacy Of Abbreviated Induction With Only 4 Cycles Of Fludarabine (F), Cyclophosphamide (C) and Rituximab (R) In Physically Fit Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Early Complete Remission (CR) With Undetectable Minimal Residual Disease (MDR)

Carolina Pavlovsky, Astrid Pavlovsky, Isolda Fernandez, Adriana Galeano, Francisco Lastiri, Santiago Pavlovsky

Blood (2013) 122 (21): 2886.

https://doi.org/10.1182/blood.V122.21.2886.2886

Published: 2013

Journal Articles

Ruxolitinib In Myelofibrosis (MF) Patients Through Compassionate Use Program (CUP). Argentinian Experience

Blood (2013) 122 (21): 5247.

https://doi.org/10.1182/blood.V122.21.5247.5247

Published: 2013

Journal Articles

PET -CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Preliminary Results in 193 Patients

Astrid Pavlovsky, Isolda Fernandez, Virginia Prates, Miguel A Pavlovsky, Lucia Zoppegno, Ana Lisa Basquiera, Federico Sackmann, Francisco Lastiri, Gustavo Milone, Santiago Pavlovsky

Blood (2011) 118 (21): 1619.

https://doi.org/10.1182/blood.V118.21.1619.1619

Published: 2011

Journal Articles

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Santiago Pavlovsky, Astrid Pavlovsky, Isolda Fernandez, Miguel Pavlovsky, Virginia Prates, Lucia Zoppegno, Ana Lisa Basquiera, Ider Cerutti, Andrea Rodriguez, Gustavo Milone, Vanesa Castano, Silvia Rudoy, Federico Sackmann, Lourdes Valles, Francisco Lastiri

Blood (2010) 116 (21): 1772.

https://doi.org/10.1182/blood.V116.21.1772.1772

Published: 2010

Journal Articles

Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Isolda Fernandez, Kihyun Kim, M.D., Guy Garay, Dong Hwan (Dennis) Kim, Silvia Saba, Chul Won Jung, Fernando Santini, MD, Haydee i Bernard, MD, Lino Salvatierra, MD, Jorge Korin, MD, Gustavo Taborda, Ricardo Antonio Giuliani, MD, Gabriela Flores, Alejandro Flores, MD

Blood (2009) 114 (22): 3809.

https://doi.org/10.1182/blood.V114.22.3809.3809

Published: 2009

Journal Articles

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Gabriela Flores, Maria Isabel Santos, MD, Graciela Alfonso, MD, Maria Cabrejo, Maria Virginia Prates, Marcelo Iastrebner, MD, Dorotea Beatriz Fantl, MD, Jorge Arbelbide, Reinaldo Campestri, MD, Diana Penchasky, MD, Paula Cardenas, MD, Federico Sackmann, Juan Garcia, MD, Elsa Nucifora, MD, Ana Basquiera, Astrid Pavlovsky, Miguel Arturo Pavlovsky, Isolda Fernandez, Susana Viñuales, MD

Blood (2009) 114 (22): 4838.

https://doi.org/10.1182/blood.V114.22.4838.4838

Published: 2009

Journal Articles

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Astrid Pavlovsky, Santiago Pavlovsky, Isolda Fernandez, Lucia Zoppegno, Ider Cerutti, Miguel Arturo Pavlovsky, Virginia Prates, Ana Basquiera, Claudia Corrado, Gustavo Milone, Maria Cabrejo, Horacio Fernandez Grecco, Graciela Avila, Viviana Flores Dutrus, Karina Gumpel, Vanina Cabanne, Silvia Saba, Francisco Lastiri

Blood (2008) 112 (11): 2592.

https://doi.org/10.1182/blood.V112.11.2592.2592

Published: 2008

Journal Articles

Monitoring Minimal Residual Disease by Quantitative PCR in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission

Blood (2008) 112 (11): 4272.

https://doi.org/10.1182/blood.V112.11.4272.4272

Published: 2008

Journal Articles

Decitabine in Myelodysplastic Syndromes: Argentine Initial Multi-Institutional Clinical Experience

Marcelo Iastrebner, MD, Virginia Prates, MD, Jorge Arbelbide, MD, Isolda Fernandez, MD, Gabriela Flores, MD, Gustavo Milone, MD, Federico Sackmann, MD, Silvia Saba, MD, Sergio Orlando, MD, Alfredo Basso, MD, Astrid Pavlovsky, MD, Gustavo Taborda, MD, Jorge Korin, MD, Julio Pose, MD

Blood (2008) 112 (11): 5086.

https://doi.org/10.1182/blood.V112.11.5086.5086

Published: 2008

Journal Articles

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Federico Sackmann, Claudia Corrado, Isolda Fernandez, Miguel A Pavlovsky, Pablo Mountford, Astrid Pavlovsky, Miguel Pavlovsky, Mariel Alejandre, Marco Pizzolato, Santiago Pavlovsky, MD, PhD

Blood (2008) 112 (11): 5123.

https://doi.org/10.1182/blood.V112.11.5123.5123

Published: 2008

Journal Articles

Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase. Experience of Argentina and Uruguay.

Blood (2006) 108 (11): 4766.

https://doi.org/10.1182/blood.V108.11.4766.4766

Published: 2006

Journal Articles

Therapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience.

Carolina Pavlovsky, MD, Santiago Pavlovsky, MD PhD, Maria L. Pardo, MD, Sandra Sapia, MD, Mariela Monreal, MD, Claudia Corrado, MDd, Miguel A. Pavlovsky, MD, Isolda Fernandez, MD, Mariana Juni, MS

Blood (2006) 108 (11): 4968.

https://doi.org/10.1182/blood.V108.11.4968.4968

Published: 2006

Journal Articles

Impact of FLT3 Mutational Status as Prognostic Factor in Acute Myeloid Leukemia Patients from Argentina and Uruguay.

Isabel Giere, PhD, Angel Chacon, MD, Rosario Uriarte, PhD, Virginia Lombardi, PhD, Isolda Fernandez, MD, Fernanda Garcia Reinoso, Ph.D, Rosana Bonomi, MD, Maria Zubillaga, PhD, Hugo Giordano, MD, Laura Pardo, PhD, Sandra Sapia, MD, Mariela Monreal, Ph.D, Lem Martinez, MD, Santiago Pavlovsky, MD, PhD

Blood (2005) 106 (11): 4494.

https://doi.org/10.1182/blood.V106.11.4494.4494

Published: 2005

NARROW

"M3-M6" Molecular Response Evolution As Early Predictor of Outcome Considering Generic Vs Branded TKIs for Chronic Myeloid Leukemia (CML): An Argentine Multicentric Study

Real-World Data from Long Term Follow-up in Chronic Myeloid Leukemia (CML) Patients (PTS) Treated with Imatinib. Predictive Factors for Achievement of Deep Molecular Responses and for Failure

Abbreviated Regimen with 4 Cycles of Fludarabine, Cyclophosphamide and Rituximab (FCR) in Physically Fit Patients with Chronic Lymphocytic Leukemia Who Achieve Early Complete Remission with Undetectable Minimal Residual Disease: Safety and Efficacy Follow-up Results of a Single Center Experience

Chronic Myeloid Leukemia (CML): BCR-ABL Transcript Levels Halving Time and Relative Reduction Ratio at Months 3 As New Predictors of Outcome. an Argentine Pilot Study

Safety and Efficacy Of Abbreviated Induction With Only 4 Cycles Of Fludarabine (F), Cyclophosphamide (C) and Rituximab (R) In Physically Fit Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Early Complete Remission (CR) With Undetectable Minimal Residual Disease (MDR)

Ruxolitinib In Myelofibrosis (MF) Patients Through Compassionate Use Program (CUP). Argentinian Experience

PET -CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Preliminary Results in 193 Patients

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Effectiveness of Decitabine in Chronic Myelomonocytic Leukemia Patients. International Cooperative Multi-Center Study.

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Monitoring Minimal Residual Disease by Quantitative PCR in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission

Decitabine in Myelodysplastic Syndromes: Argentine Initial Multi-Institutional Clinical Experience

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase. Experience of Argentina and Uruguay.

Therapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience.

Impact of FLT3 Mutational Status as Prognostic Factor in Acute Myeloid Leukemia Patients from Argentina and Uruguay.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only